Online Message×
Click switch
About Us
More than 17 + Years
More than 17+ years of experience in new drug R&D
1100 +
Active clients worldwide
2000 +
Clinical pharmaceutical scientists and service personnel
73800 + Square meters of
Laboratory floor space
165 Projects
Successfully registered with relevant authorities
Company Profile


Medicilon is an integrated biomedical contract research organization (CRO), providing comprehensive one-step new drug R&D for pharmaceutical enterprises and scientific research institutions around the world.Our services cover the entire preclinical new drug research process, including drug discovery, pharmaceutical research, and preclinical research.Drug discovery includes: Protein target verification, structural biologychemical synthesis, active screening and optimization of compounds; Pharmaceutical research includes: API and preparation process, research on quality standards and stability; Pre-clinical research includes: Pharmacodynamics pharmacokinetics toxicology, and drug safety evaluation.

Based on key links of drug R&D, we focus on the demand for innovation and the development of the global pharmaceutical industry. With our experience in serving domestic and foreign biomedical industries, we have built an integrated technical platform covering key technologies in drug discovery, pharmaceutical research, and preclinical research, in a bid to provide comprehensive preclinical new drug R&D for the global biomedical industry.

Zhangjiang High-Tech Park, Shanghai (Zhangjiang Branch)

Address: Building No. 5, Lane 67, Libing Road, Zhangjiang High-Tech Park

Tel: +86 (21) 5132-0237

Fax: +86 (21) 5132-0222

Postcode: 201203

01 / 03
Shanghai Pudong Chuansha Economic Park (Chuansha Headquarters)

Address: No. 585 Chuanda Road, Pudong New Area, Shanghai

Tel: +86 (21) 5859-1500

Fax: +86 (21) 5859-6369

Postcode: 201299

02 / 03
Medicilon Industrial Park (Nanhui Branch)

Address: Medicilon Industrial Park, No. 2300 Xuanhuang Road, Pudong New Area, Shanghai

Tel: +86 (21) 6898-5800

Postcode: 201300

03 / 03
Innovation Platform
Innovation platform

Medicilon is a pharmaceutical R&D and contract research organization (CRO) based in Shanghai. We have created a comprehensive technical service platform that integrates compound synthesis, compound activity screening, structural biology, pharmacodynamics evaluation, pharmacokinetics evaluation, toxicology evaluation, preparation research, and new drug filing. We operate in compliance with international standards and are recognized by international drug administrations.In February 2008, Medicilon established Medicilon Preclinical Research (Shanghai) LLC, a subsidiary with a focus on preclinical pharmacokinetics and safety evaluation research.MPI’s animal experiment facilities have been accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), and has obtained NMPA GLP and FDA GLP certification.Our integrated services help clients achieve their R&D goals with efficiency and professionalism while spending less time and cost.

Contact Us
We strive to provide all-round preclinical research for pharmaceutical companies, research institutions and all scientific researchers worldwide.